Further evidence that noradrenaline is not involved in the anti-immobility activity of chronic desipramine in the rat
- 1 April 1987
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 136 (3), 429-432
- https://doi.org/10.1016/0014-2999(87)90319-0
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Antagonism by dopamine, but not noradrenaline receptor blockers of the anti-immobility activity of desipramine after different treatment schedules in the ratPharmacological Research Communications, 1986
- Evidence of dopamine involvement in the effect of repeated treatment with various antidepressants in the behavioural ‘despair’ test in ratsEuropean Journal of Pharmacology, 1985
- Effect of repeated treatment with desipramine in the behavioral “despair” test in rats: Antagonism by “atypical” but not “classical” neuroleptics or antiadrenergic drugsLife Sciences, 1984
- Involvement of α- and β1-adrenergic mechanisms in the immobility-reducing action of desipramine in the forced swimming testNeuropharmacology, 1983
- Immobility test: effects of 5-hydroxytryptaminergic drugs and role of catecholamines in the activity of some antidepressantsJournal of Pharmacy and Pharmacology, 1981
- DSP4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine)—A useful denervation tool for central and peripheral noradrenaline neuronsEuropean Journal of Pharmacology, 1981
- Liquid chromatographic analysis of catecholamines routine assay for regional brain mappingLife Sciences, 1976
- Stereotaxic Mapping of the Monoamine Pathways in the Rat Brain*Acta Physiologica Scandinavica, 1971